
ProsTIC26: Prospective Evaluation of Amino Acid Co-Infusion for Renal Dose Reduction During 177Lu-PSMA-I&T Therapy: Interim Results from the RENOGUARD Trial
<a href="https://news.google.com/rss/articles/CBMiygJBVV95cUxOVVJGZHZwNllLNTRKN3VoTF91TXhQRDR3TDlhNjVjZ3ZXcDlVc2l3aGxpTmpGdmVYX29vSURwQVIzN3lYLVdQR3lNSEdFd3BJc3RjaHFpVTRHR3ZrSTFoR0o3WFhJMmNXcWd6Q3pyREpPNUU2eFZ4OGpyMDBKRFRxOEtxSjVYMWU0TDhDUjVrbjdxaFBmalJZQVkzZ3BVOFQxLWhPVC10WXQ4UEc1aDFUU3NRWS1uc0RHdmpsTXRIN0JfdzRUcWhRUE1JdFhuZXc1ZnBsVlFtV3c4WkRBWjVJZGtMM1A0UVNqSzBsYVN1akp0N1NqVjFhcGxLdC1GQnhSRTdkd1BWVHllM3ZrcXBTU2IyZXdWa1cyOVNOOS1Hbko0b0xvUDM1Z1E1UEFZMjZDa3J2VnlYdF92bGR0RjJZdGJaVmgtX19UYUE?oc=5" target="_blank">ProsTIC26: Prospective Evaluation of Amino Acid Co-Infusion for Renal Dose Reduction During 177Lu-PSMA-I&T Therapy: Interim Results from the RENOGUARD Trial</a>&nbsp;&nbsp;<font color="#6f6f6f">UroToday</font>

